BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

920 related articles for article (PubMed ID: 17049083)

  • 1. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
    Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
    BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
    Weller M; Müller B; Koch R; Bamberg M; Krauseneck P;
    J Clin Oncol; 2003 Sep; 21(17):3276-84. PubMed ID: 12947063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nimustine (ACNU) plus teniposide (VM26) in recurrent glioblastoma.
    Glas M; Hundsberger T; Stuplich M; Wiewrodt D; Kurzwelly D; Nguyen-Huu B; Rasch K; Herrlinger U
    Oncology; 2009; 76(3):184-9. PubMed ID: 19218824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
    Mizoe JE; Tsujii H; Hasegawa A; Yanagi T; Takagi R; Kamada T; Tsuji H; Takakura K;
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):390-6. PubMed ID: 17459607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305).
    Shibui S; Narita Y; Mizusawa J; Beppu T; Ogasawara K; Sawamura Y; Kobayashi H; Nishikawa R; Mishima K; Muragaki Y; Maruyama T; Kuratsu J; Nakamura H; Kochi M; Minamida Y; Yamaki T; Kumabe T; Tominaga T; Kayama T; Sakurada K; Nagane M; Kobayashi K; Nakamura H; Ito T; Yazaki T; Sasaki H; Tanaka K; Takahashi H; Asai A; Todo T; Wakabayashi T; Takahashi J; Takano S; Fujimaki T; Sumi M; Miyakita Y; Nakazato Y; Sato A; Fukuda H; Nomura K
    Cancer Chemother Pharmacol; 2013 Feb; 71(2):511-21. PubMed ID: 23228988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary CNS lymphoma treated with combined intra-arterial ACNU and radiotherapy.
    Sonoda Y; Matsumoto K; Kakuto Y; Nishino Y; Kumabe T; Tominaga T; Katakura R
    Acta Neurochir (Wien); 2007 Nov; 149(11):1183-9; discussion 1189. PubMed ID: 17712511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
    Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sequential chemo-radiotherapeutic treatment for patients with malignant gliomas: a phase II pilot study.
    Dazzi C; Cariello A; Giannini M; Del Duca M; Giovanis P; Fiorentini G; Leoni M; Rosti G; Turci D; Tienghi A; Vertogen B; Zumaglini F; De Giorgi U; Marangolo M
    Anticancer Res; 2000; 20(1B):515-8. PubMed ID: 10769716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open-label simultaneous radio-chemotherapy of glioblastoma multiforme with topotecan in adults.
    Gross MW; Altscher R; Brandtner M; Haeusser-Mischlich H; Chiricuta IC; Siegmann AD; Engenhart-Cabillic R
    Clin Neurol Neurosurg; 2005 Apr; 107(3):207-13. PubMed ID: 15823676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
    Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
    Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome and prognostic factors in cerebellar glioblastoma multiforme in adults: a retrospective study from the Rare Cancer Network.
    Weber DC; Miller RC; Villà S; Hanssens P; Baumert BG; Castadot P; Varlet P; Abacioglu U; Igdem S; Szutowicz E; Nishioka H; Hofer S; Rutz HP; Ozsahin M; Taghian A; Mirimanoff RO
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):179-86. PubMed ID: 16814953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic analysis of patients with cerebral glioma treated with radiotherapy].
    Wu SX; Deng ML; Li QQ; Zhao C; Lu TX; Li FY; Cui NJ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1561-6. PubMed ID: 15566680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glioblastoma multiforme-report of 267 cases treated at a single institution.
    Stark AM; Nabavi A; Mehdorn HM; Blömer U
    Surg Neurol; 2005 Feb; 63(2):162-9; discussion 169. PubMed ID: 15680662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas: benefit for selected patients.
    Fernández-Hidalgo OA; Vanaclocha V; Vieitez JM; Aristu JJ; Rebollo J; Gúrpide A; Aramendía JM; Moreno-Palanques R; Martín-Algarra S; Subirá ML; Brugarolas A
    Bone Marrow Transplant; 1996 Jul; 18(1):143-9. PubMed ID: 8832007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Individualized therapy and outcomes of microsurgery, radiotherapy, and chemotherapy for astrocytoma].
    Zhou WN; Chen ZP; You C; Mu YG; Sai K; Zhang JY; Zhang XH; Cheng JJ; Xu HC
    Ai Zheng; 2004 Nov; 23(11 Suppl):1555-60. PubMed ID: 15566679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM).
    Combs SE; Widmer V; Thilmann C; Hof H; Debus J; Schulz-Ertner D
    Cancer; 2005 Nov; 104(10):2168-73. PubMed ID: 16220556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 12 years' experience with intraoperative radiotherapy (IORT) of malignant gliomas.
    Schueller P; Micke O; Palkovic S; Schroeder J; Moustakis C; Bruns F; Schuck A; Wassmann H; Willich N
    Strahlenther Onkol; 2005 Aug; 181(8):500-6. PubMed ID: 16044217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme.
    Lipani JD; Jackson PS; Soltys SG; Sato K; Adler JR
    Technol Cancer Res Treat; 2008 Jun; 7(3):249-55. PubMed ID: 18473497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of radiotherapy after hyperbaric oxygenation with multiagent chemotherapy (procarbazine, nimustine, and vincristine) for high-grade gliomas: long-term results.
    Ogawa K; Ishiuchi S; Inoue O; Yoshii Y; Saito A; Watanabe T; Iraha S; Toita T; Kakinohana Y; Ariga T; Kasuya G; Murayama S
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):732-8. PubMed ID: 21420247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short course of radiation therapy in elderly patients with glioblastoma multiforme.
    Idbaih A; Taillibert S; Simon JM; Psimaras D; Schneble HM; Lopez S; Lang P; Toubiana T; Feuvret L; Delattre JY; Mazeron JJ
    Cancer Radiother; 2008 Dec; 12(8):788-92. PubMed ID: 19046921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.